By way of derogation from the first subparagraph , in the case of a decision not to approve an active substance , a Member State may continue to apply its current system or practice of making biocidal products available on the market for up to 12 months after the date of the decision not to approve an active substance in accordance with the third subparagraph of paragraph 1 , and .